Ashok Leyland Sales Up 5% in September

Sep 01, 2025 13:01

Ashok Leyland reports a 5% increase in September sales, reaching 15,239 units. Domestic sales grew by 2%. Stock update included.

Photograph: Kind courtesy Ashok Leyland/Instagram

New Delhi, Sep 1 (PTI) Commercial vehicles maker Ashok Leyland on Monday reported a 5 per cent year-on-year increase in total sales at 15,239 units in August.

The company had sold a total of 14,463 units in August 2024, Ashok Leyland said in a statement.

Domestic sales grew 2 per cent at 13,622 units as against 13,347 units in the year-ago month, it added.

Shares of the company were trading 0.16 per cent down at Rs 126.70 apiece on BSE.

Source: PTI

MORE NEWS

SBI MD: Concerns Over Account Aggregator Consent

SBI MD Ashwini Kumar Tewari raises concerns about Account Aggregator's single consent...

Silver Hits Record High on Fed Rate Cut Hopes

Silver futures soar to Rs 1.91 lakh/kg on Fed rate cut expectations. Gold rises. Market...

SpiceJet Adds 100 Daily Flights for Winter Demand

SpiceJet plans to add up to 100 daily flights this winter to meet growing demand and...

2 Lakh Startups Recognised by Govt: Startup India

Government recognizes over 2 lakh startups under Startup India. Incentives, job...

Waaree Energies: 1 GW Solar Module Output Record

Waaree Energies achieves record 1 GW monthly solar module output in November 2025, a...

India FTA Talks with Oman, New Zealand Nearing End

Piyush Goyal announces FTA negotiations with Oman, New Zealand in final stages. Trade...

Telangana to Launch Rs 1,000 Cr Startup Fund

Telangana CM announces Rs 1,000 crore startup fund to boost Hyderabad as a unicorn hub....

ADB Raises India GDP Growth Forecast to 7.2%...

ADB sharply revises India''s GDP growth forecast upward to 7.2% for FY26, driven by...

India, EU FTA Talks Progress: Goyal Comments

Piyush Goyal says India and EU are committed to early conclusion of FTA negotiations. A...

Zydus Launches Denosumab Biosimilar Zyrifa

Zydus Lifesciences launches Zyrifa, a Denosumab biosimilar for osteoporosis and...

Ashok Leyland Sales Up 5% in September

You May Like To Read

MORE NEWS